Practice Portal

Go to Samples

Eli Lilly and Co.

Jaypirca

100mg x 30 per package

Indications and Usage

Mantle Cell Lymphoma

JAYPIRCA® is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.

This indication is approved under accelerated approval based on response rate [see Clinical Studies ]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

JAYPIRCA is indicated for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have received at least two prior lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor.

More than 200,000 clinicians have integrated PrescriberPoint into their clinical workflows

HOW IT WORKS

The easy way to access samples

Confirm EligibilitySamples are available for authorized US healthcare providers

Create Free AccountRequest, track, and manage samples from multiple brands

Get your SampleSamples shipped directly to your practice door

Want to check your eligibility to order samples?

WHO IS PRESCRIBERPOINT

Increasing patient access to medications they need

At PrescriberPoint, we're revolutionizing how healthcare providers get patients the medications they need. We craft solutions that help providers address the challenges in patient access and improve outcomes.

200K+Visitors Each Month

100K+Engagements Each Month

1M+Resources Viewed

WHAT HCPS ARE SAYING

FAQs

All you need to know to order samples

Currently, PrescriberPoint is available only in the U.S, but we are excited to expand our reach in the future! Stay connected by following us or signing up for our newsletter to get the latest updates, including announcements about new market launches.